Beyond canonical deficits in social cognition and interpersonal conduct, behavioral variant frontotemporal dementia (bvFTD) involves language difficulties in a substantial proportion of cases. However, since most evidence comes from high-income countries, the scope and relevance of language deficits in Latin American bvFTD samples remain poorly understood. As a first step toward reversing this scenario, we review studies reporting language measures in Latin American bvFTD cohorts relative to other groups. We identified 24 papers meeting systematic criteria, mainly targeting phonemic and semantic fluency, naming, semantic processing, and comprehension skills. The evidence shows widespread impairments in these domains, often related to overall cognitive disturbances. Some of these deficits may be as severe as in other diseases where they are more widely acknowledged, such as Alzheimer's disease. Considering the prevalence and informativeness of language deficits in bvFTD patients from other world regions, the need arises for more systematic research in Latin America, ideally spanning multiple domains, in diverse languages and dialects, with validated batteries. We outline key challenges and pathways of progress in this direction, laying the ground for a new regional research agenda on the disorder.
Background The capacity to ascertain other people’s emotional states is crucial for establishing and maintaining social interactions. In particular, accurate recognition of facial expressions and beliefs about whether we trust what a face transmits are fundamental for guiding and adjusting this social behavior. Yet, although emotion recognition impairments are well documented in neurodegenerative diseases, the role of monitoring skills in this domain remains poorly understood in the field of dementia. Method We recruited patients with behavioral variant frontotemporal dementia (bvFTD, n = 18), Alzheimer’s disease (AD, n = 27), and demographically‐matched controls (n = 38). Participants performed a classic test of facial expression recognition and, after each trial, they provided a confidence judgment about their performance. A monitoring index was calculated considering both performance on each emotion type and associated confidence ratings (with higher values of the index indicating worse monitoring). Then, whole‐brain grey matter volume was analyzed via voxel‐based morphometry (VBM) to track possible associations with the monitoring index. Results Compared to controls, both groups of patients exhibited difficulties in monitoring negative emotions. Monitoring of disgust was specifically impaired in bvFTD, and monitoring of sadness and neutral faces, in AD. VBM results showed that, in bvFTD, reduced grey matter volume in areas belonging to the limbic system and subcortical regions was associated with emotion recognition deficits. Monitoring impairments were also related with different subcortical and cortical areas, including the prefrontal lobe, insula and the cingulate cortex. On the other hand, in AD, temporal and parietal areas were associated with emotion recognition and parietal and frontal regions, with monitoring. Conclusion These results indicate that dementia patients present emotion recognition monitoring impairments and that these deficits are associated with damage of cortical and subcortical regions as well as limbic circuits. In both groups, recognition and monitoring of emotions shared several structural substrates. The monitoring impairments presented in bvFTD and AD could be related with the changes in social cognition and behavior that these patients presented in daily life. Therefore, these preliminary findings could contribute to a better understanding of emotion monitoring processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.